Aspire Biopharma Holdings, Inc. 10-Q filing
Filed 2025-08-13 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001641172-25-023573
- Form type
- 10-Q
- CIK
- 0001847345
- Primary document
- https://www.sec.gov/Archives/edgar/data/1847345/000164117225023573/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspire Biopharma Holdings, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Net Income | $-17.9M | - | - |
| Total Assets | $989,422 | - | - |
| Total Liabilities | $10.6M | - | - |
| Shareholders Equity | $-9.6M | - | - |
| Operating Cash Flow | $-2.9M | - | - |